Covaxin may get WHO LE this week, the NTAGI official says

“We should get the WHO EUL for Covaxin this week. The vaccine should gain international recognition with this. Posting approvals who want to travel abroad will have no difficulty, ”Arora said.

The Minister of Health of the Union, Mansukh Mandaviya, met on August 12 with the Chief Scientist of the World Health Organization (WHO), Soumya Swaminathan, to discuss the approval of the World Health Organization. ‘UN for the covid-19 vaccine Covaxin from Bharat Biotech. Swaminathan in July said the WHO could make a decision on granting an emergency use list (EUL) to Covaxin in four to six weeks.

The WHO Emergency Use List (EUL) is a prerequisite for the supply of vaccines from the COVAX facility to other countries. The EU assesses the quality, safety and efficacy of covid-19 vaccines, as well as risk management plans and programmatic suitability, such as cold chain requirements. The evaluation is carried out by the product evaluation group, made up of regulatory experts from around the world and a technical advisory group (TAG), responsible for carrying out the risk-benefit assessment to obtain an independent recommendation on whether include a vaccine for emergency use. and, if so, under what conditions. So far, the WHO has given EUL to six vaccines.

According to reports, Mariangela Simao, WHO Deputy Director-General for Vaccines, said the UN health agency’s assessment of the Bharat Biotech vaccine was “quite advanced” and officials were waiting for a decision. in mid-September.

Covaxin, India’s first indigenous covid vaccine, has also received US from 14 countries and another 50 in the process. In June, the drug maker had said that its US partner, Ocugen, received a recommendation from the U.S. Food and Drug Administration to follow the path of organic product license (BLA) applications for Covaxin , which is a total approval. Applications must follow the BLA process, which is the standard for vaccines.

Bharat Biotech is also exploring manufacturing partnerships with its partners in other countries, who have previous experience in commercial-scale manufacturing of inactivated viral vaccines under biosafety containment for further increase.

According to the Union Ministry of Health, more than 72.77 doses of vaccine (including all available vaccines (covaxine, covishield and sputnik)) have so far been provided to States / UTs through the governments of India ( free channel) hiring category. In addition, there are more than 1.6 doses of Crore in process.

More than 4.49 unused crude balances and doses of covid-19 vaccine are still available in the States / UT for administration.

India’s covid-19 vaccination coverage crossed 75.81 million (75.81,99,331) on Tuesday.

The recovery of 37,127 patients in the last 24 hours has increased the cumulative count of patients recovered (since the beginning of the pandemic) to 3.24.84.159. As a result, India’s recovery rate stands at 97.58%.

More than 25,404 new cases of coronavirus have been reported in the last 24 hours. Currently, the active case load is 3,62,207. Currently, active cases constitute 1.09% of the total positive cases in the country. To date, India has conducted more than 54.44 accumulated covid-19 tests. On Tuesday it was reported that the daily positivity rate was 1.78%.